250 related articles for article (PubMed ID: 15684407)
1. Biomarkers: mining the biofluid proteome.
Veenstra TD; Conrads TP; Hood BL; Avellino AM; Ellenbogen RG; Morrison RS
Mol Cell Proteomics; 2005 Apr; 4(4):409-18. PubMed ID: 15684407
[TBL] [Abstract][Full Text] [Related]
2. Emerging Affinity-Based Proteomic Technologies for Large-Scale Plasma Profiling in Cardiovascular Disease.
Smith JG; Gerszten RE
Circulation; 2017 Apr; 135(17):1651-1664. PubMed ID: 28438806
[TBL] [Abstract][Full Text] [Related]
3. Proteomics approaches to biomarker detection.
Zhou M; Conrads TP; Veenstra TD
Brief Funct Genomic Proteomic; 2005 May; 4(1):69-75. PubMed ID: 15975266
[TBL] [Abstract][Full Text] [Related]
4. Contributions of immunoaffinity chromatography to deep proteome profiling of human biofluids.
Wu C; Duan J; Liu T; Smith RD; Qian WJ
J Chromatogr B Analyt Technol Biomed Life Sci; 2016 May; 1021():57-68. PubMed ID: 26868616
[TBL] [Abstract][Full Text] [Related]
5. Biomarker discovery in mass spectrometry-based urinary proteomics.
Thomas S; Hao L; Ricke WA; Li L
Proteomics Clin Appl; 2016 Apr; 10(4):358-70. PubMed ID: 26703953
[TBL] [Abstract][Full Text] [Related]
6. Plasma/Serum Proteomics based on Mass Spectrometry.
Zhu Y
Protein Pept Lett; 2024; 31(3):192-208. PubMed ID: 38869039
[TBL] [Abstract][Full Text] [Related]
7. The plasma proteome, adductome and idiosyncratic toxicity in toxicoproteomics research.
Merrick BA
Brief Funct Genomic Proteomic; 2008 Jan; 7(1):35-49. PubMed ID: 18270218
[TBL] [Abstract][Full Text] [Related]
8. Serum and plasma proteomics and its possible use as detector and predictor of radiation diseases.
Guipaud O
Adv Exp Med Biol; 2013; 990():61-86. PubMed ID: 23378003
[TBL] [Abstract][Full Text] [Related]
9. Revisiting biomarker discovery by plasma proteomics.
Geyer PE; Holdt LM; Teupser D; Mann M
Mol Syst Biol; 2017 Sep; 13(9):942. PubMed ID: 28951502
[TBL] [Abstract][Full Text] [Related]
10. Challenges and Opportunities in Clinical Applications of Blood-Based Proteomics in Cancer.
Bhawal R; Oberg AL; Zhang S; Kohli M
Cancers (Basel); 2020 Aug; 12(9):. PubMed ID: 32867043
[TBL] [Abstract][Full Text] [Related]
11. Computational biomarker pipeline from discovery to clinical implementation: plasma proteomic biomarkers for cardiac transplantation.
Cohen Freue GV; Meredith A; Smith D; Bergman A; Sasaki M; Lam KK; Hollander Z; Opushneva N; Takhar M; Lin D; Wilson-McManus J; Balshaw R; Keown PA; Borchers CH; McManus B; Ng RT; McMaster WR;
PLoS Comput Biol; 2013 Apr; 9(4):e1002963. PubMed ID: 23592955
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of multiprotein immunoaffinity subtraction for plasma proteomics and candidate biomarker discovery using mass spectrometry.
Liu T; Qian WJ; Mottaz HM; Gritsenko MA; Norbeck AD; Moore RJ; Purvine SO; Camp DG; Smith RD
Mol Cell Proteomics; 2006 Nov; 5(11):2167-74. PubMed ID: 16854842
[TBL] [Abstract][Full Text] [Related]
13. Detection of new screening markers for fetal aneuploidies in maternal plasma: a proteomic approach.
Reddy CS; Holzgreve W; Hahn S
Methods Mol Biol; 2008; 444():311-26. PubMed ID: 18425492
[TBL] [Abstract][Full Text] [Related]
14. Biomarker discovery from the plasma proteome using multidimensional fractionation proteomics.
Lee HJ; Lee EY; Kwon MS; Paik YK
Curr Opin Chem Biol; 2006 Feb; 10(1):42-9. PubMed ID: 16418010
[TBL] [Abstract][Full Text] [Related]
15. Mining the acidic serum proteome utilizing off-gel isoelectric focusing and label free quantitative liquid chromatography mass spectrometry.
Smith J; Davey G; Polom K; Roviello F; Bones J
J Chromatogr A; 2018 Sep; 1566():32-43. PubMed ID: 29945787
[TBL] [Abstract][Full Text] [Related]
16. Microscale depletion of high abundance proteins in human biofluids using IgY14 immunoaffinity resin: analysis of human plasma and cerebrospinal fluid.
Hyung SW; Piehowski PD; Moore RJ; Orton DJ; Schepmoes AA; Clauss TR; Chu RK; Fillmore TL; Brewer H; Liu T; Zhao R; Smith RD
Anal Bioanal Chem; 2014 Nov; 406(28):7117-25. PubMed ID: 25192788
[TBL] [Abstract][Full Text] [Related]
17. SWATH-MS Protocols in Human Diseases.
Chantada-Vázquez MDP; García Vence M; Serna A; Núñez C; Bravo SB
Methods Mol Biol; 2021; 2259():105-141. PubMed ID: 33687711
[TBL] [Abstract][Full Text] [Related]
18. Investigation of the efficacy of albumin removal procedures on porcine serum proteome profile.
Grubbs JK; Tuggle CK; Dekkers JC; Boddicker NJ; Nguyen YT; Huff-Lonergan E; Nettleton D; Lonergan SM
J Anim Sci; 2015 Apr; 93(4):1592-8. PubMed ID: 26020181
[TBL] [Abstract][Full Text] [Related]
19. A Versatile Workflow for Cerebrospinal Fluid Proteomic Analysis with Mass Spectrometry: A Matter of Choice between Deep Coverage and Sample Throughput.
Macron C; Núñez Galindo A; Cominetti O; Dayon L
Methods Mol Biol; 2019; 2044():129-154. PubMed ID: 31432411
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
